PMC:7647877 / 22910-23289
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T308 | 20-22 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
| T309 | 255-257 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
| T310 | 324-326 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T141 | 110-118 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T142 | 224-231 | Disease | denotes | obesity | http://purl.obolibrary.org/obo/MONDO_0011122 |
| T143 | 354-362 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T207 | 20-22 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T209 | 255-257 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T211 | 324-326 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T50 | 42-62 | Phenotype | denotes | acute phase response | http://purl.obolibrary.org/obo/HP_0033331 |
| T51 | 224-231 | Phenotype | denotes | obesity | http://purl.obolibrary.org/obo/HP_0001513 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T115 | 42-62 | http://purl.obolibrary.org/obo/GO_0006953 | denotes | acute phase response |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T141 | 0-128 | Sentence | denotes | The pivotal role of IL-6 in mediating the acute phase response seems to interest the strategical treatment in COVID-19 patients. |
| T142 | 129-379 | Sentence | denotes | Researches are still in progress and it would be intriguing to investigate whether people with obesity and higher circulating IL-6 levels, compared with lean controls, respond more favourably to IL-6 inhibition strategies in SARS-CoV-2 pandemic [43]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 652 | 20-24 | Gene | denotes | IL-6 | Gene:3569 |
| 653 | 255-259 | Gene | denotes | IL-6 | Gene:3569 |
| 654 | 324-328 | Gene | denotes | IL-6 | Gene:3569 |
| 655 | 119-127 | Species | denotes | patients | Tax:9606 |
| 656 | 212-218 | Species | denotes | people | Tax:9606 |
| 657 | 354-364 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 658 | 110-118 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 659 | 224-231 | Disease | denotes | obesity | MESH:D009765 |